FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

258684004: milligram (qualifier value)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
384907012 mg en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
384908019 milligram en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
2609697015 milligram (qualifier value) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT core
856061000241111 milligramme fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
mg Is a SI unit of mass true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Benserazide 12.5 mg and levodopa 50 mg oral tablet This attribute specifies the numerator unit for the presentation strength of a product. True mg Inferred relationship Some 2
Benserazide 12.5 mg and levodopa 50 mg oral tablet This attribute specifies the numerator unit for the presentation strength of a product. True mg Inferred relationship Some 1
Product containing precisely dextromethorphan hydrobromide 30 milligram and guaifenesin 600 milligram/1 each prolonged-release oral tablet (clinical drug) This attribute specifies the numerator unit for the presentation strength of a product. True mg Inferred relationship Some 1
Product containing precisely dextromethorphan hydrobromide 30 milligram and guaifenesin 600 milligram/1 each prolonged-release oral tablet (clinical drug) This attribute specifies the numerator unit for the presentation strength of a product. True mg Inferred relationship Some 2
Product containing precisely benserazide 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) This attribute specifies the numerator unit for the presentation strength of a product. True mg Inferred relationship Some 1
Product containing precisely benserazide 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) This attribute specifies the numerator unit for the presentation strength of a product. True mg Inferred relationship Some 2
Procaine 100 mg/mL solution for injection This attribute specifies the numerator unit for the concentration strength of a product. True mg Inferred relationship Some 1
Product containing precisely salbutamol (as salbutamol sulfate) 2 milligram/1 milliliter conventional release solution for inhalation (clinical drug) This attribute specifies the numerator unit for the concentration strength of a product. False mg Inferred relationship Some 1
Menthol 30 microgram/mg and methyl salicylate 100 microgram/mg cutaneous patch This attribute specifies the denominator unit for the concentration strength of a product. True mg Inferred relationship Some 1
Menthol 30 microgram/mg and methyl salicylate 100 microgram/mg cutaneous patch This attribute specifies the denominator unit for the concentration strength of a product. True mg Inferred relationship Some 2
Botulism immunoglobulin 100 mg powder for solution for injection vial This attribute specifies the numerator unit for the presentation strength of a product. True mg Inferred relationship Some 1
Product containing precisely aclarubicin 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) This attribute specifies the numerator unit for the presentation strength of a product. True mg Inferred relationship Some 1
Product containing precisely amoxicillin anhydrous (as amoxicillin) 40 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 5.7 milligram/1 milliliter conventional release oral suspension (clinical drug) This attribute specifies the numerator unit for the concentration strength of a product. False mg Inferred relationship Some 1
Product containing precisely amoxicillin anhydrous (as amoxicillin) 40 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 5.7 milligram/1 milliliter conventional release oral suspension (clinical drug) This attribute specifies the numerator unit for the concentration strength of a product. False mg Inferred relationship Some 2
Product containing precisely cefaclor anhydrous (as cefaclor) 250 milligram/1 each conventional release chewable tablet (clinical drug) This attribute specifies the numerator unit for the presentation strength of a product. False mg Inferred relationship Some 1
Product containing precisely albiglutide 30 milligram/1 pen powder for conventional release solution for injection (clinical drug) This attribute specifies the numerator unit for the presentation strength of a product. True mg Inferred relationship Some 1
Albiglutide 50 mg powder for solution for injection pen This attribute specifies the numerator unit for the presentation strength of a product. True mg Inferred relationship Some 1
Camphor 12 microgram/mg and menthol 57 microgram/mg and methyl salicylate 63 microgram/mg cutaneous patch This attribute specifies the denominator unit for the concentration strength of a product. True mg Inferred relationship Some 1
Camphor 12 microgram/mg and menthol 57 microgram/mg and methyl salicylate 63 microgram/mg cutaneous patch This attribute specifies the denominator unit for the concentration strength of a product. True mg Inferred relationship Some 2
Camphor 12 microgram/mg and menthol 57 microgram/mg and methyl salicylate 63 microgram/mg cutaneous patch This attribute specifies the denominator unit for the concentration strength of a product. True mg Inferred relationship Some 3
Trastuzumab 440 mg powder for solution for injection vial This attribute specifies the numerator unit for the presentation strength of a product. True mg Inferred relationship Some 1
Product containing precisely amoxicillin anhydrous (as amoxicillin) 400 milligram and clavulanic acid (as clavulanate potassium) 57 milligram/1 each conventional release chewable tablet (clinical drug) This attribute specifies the numerator unit for the presentation strength of a product. False mg Inferred relationship Some 1
Product containing precisely amoxicillin anhydrous (as amoxicillin) 400 milligram and clavulanic acid (as clavulanate potassium) 57 milligram/1 each conventional release chewable tablet (clinical drug) This attribute specifies the numerator unit for the presentation strength of a product. False mg Inferred relationship Some 2
Doxycycline anhydrous (as doxycycline) 75 mg orodispersible tablet This attribute specifies the numerator unit for the presentation strength of a product. True mg Inferred relationship Some 1
Varicella-zoster virus antibody 500 mg powder for solution for injection vial This attribute specifies the numerator unit for the presentation strength of a product. True mg Inferred relationship Some 1
Product containing precisely Varicella-zoster virus antibody 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) This attribute specifies the numerator unit for the presentation strength of a product. True mg Inferred relationship Some 1
Product containing precisely hydrocortisone 1.67 milligram/1 milliliter conventional release rectal suspension (clinical drug) This attribute specifies the numerator unit for the concentration strength of a product. True mg Inferred relationship Some 1
Doxycycline anhydrous (as doxycycline) 5 mg/mL oral suspension This attribute specifies the numerator unit for the concentration strength of a product. True mg Inferred relationship Some 1
Product containing precisely dyclonine hydrochloride 10 milligram/1 milliliter conventional release cutaneous solution (clinical drug) This attribute specifies the numerator unit for the concentration strength of a product. True mg Inferred relationship Some 1
Drotrecogin alfa 5 mg powder for solution for injection vial This attribute specifies the numerator unit for the presentation strength of a product. True mg Inferred relationship Some 1
Product containing precisely cefaclor anhydrous (as cefaclor) 37.4 milligram/1 milliliter conventional release oral suspension (clinical drug) This attribute specifies the numerator unit for the concentration strength of a product. True mg Inferred relationship Some 1
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem anhydrous (as imipenem) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) This attribute specifies the numerator unit for the presentation strength of a product. True mg Inferred relationship Some 2
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem anhydrous (as imipenem) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) This attribute specifies the numerator unit for the presentation strength of a product. True mg Inferred relationship Some 1
Product containing precisely levofloxacin anhydrous (as levofloxacin) 15 milligram/1 milliliter conventional release eye solution (clinical drug) This attribute specifies the numerator unit for the concentration strength of a product. True mg Inferred relationship Some 1
Product containing precisely cefalexin anhydrous (as cefalexin) 50 milligram/1 milliliter conventional release oral suspension (clinical drug) This attribute specifies the numerator unit for the concentration strength of a product. True mg Inferred relationship Some 1
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet This attribute specifies the numerator unit for the presentation strength of a product. True mg Inferred relationship Some 1
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet This attribute specifies the numerator unit for the presentation strength of a product. True mg Inferred relationship Some 2
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet This attribute specifies the numerator unit for the presentation strength of a product. True mg Inferred relationship Some 3
Product containing precisely erythromycin (as erythromycin lactobionate) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) This attribute specifies the numerator unit for the presentation strength of a product. True mg Inferred relationship Some 1
Levofloxacin anhydrous (as levofloxacin) 5 mg/mL eye solution This attribute specifies the numerator unit for the concentration strength of a product. True mg Inferred relationship Some 1
Carbidopa anhydrous (as carbidopa) 18.75 mg and entacapone 200 mg and levodopa 75 mg oral tablet This attribute specifies the numerator unit for the presentation strength of a product. True mg Inferred relationship Some 1
Carbidopa anhydrous (as carbidopa) 18.75 mg and entacapone 200 mg and levodopa 75 mg oral tablet This attribute specifies the numerator unit for the presentation strength of a product. True mg Inferred relationship Some 3
Carbidopa anhydrous (as carbidopa) 18.75 mg and entacapone 200 mg and levodopa 75 mg oral tablet This attribute specifies the numerator unit for the presentation strength of a product. True mg Inferred relationship Some 2
Human alpha1 proteinase inhibitor 500 mg powder for solution for injection vial This attribute specifies the numerator unit for the presentation strength of a product. True mg Inferred relationship Some 1
Product containing precisely levofloxacin anhydrous (as levofloxacin) 25 milligram/1 milliliter conventional release oral solution (clinical drug) This attribute specifies the numerator unit for the concentration strength of a product. True mg Inferred relationship Some 1
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) This attribute specifies the numerator unit for the presentation strength of a product. True mg Inferred relationship Some 1
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) This attribute specifies the numerator unit for the presentation strength of a product. True mg Inferred relationship Some 2
Product containing precisely cannabinol 25 milligram/1 milliliter and tetrahydrocannabinol 27 milligram/1 milliliter conventional release oral spray (clinical drug) This attribute specifies the numerator unit for the concentration strength of a product. False mg Inferred relationship Some 1
Product containing precisely cannabinol 25 milligram/1 milliliter and tetrahydrocannabinol 27 milligram/1 milliliter conventional release oral spray (clinical drug) This attribute specifies the numerator unit for the concentration strength of a product. False mg Inferred relationship Some 2
Warfarin sodium 5 mg powder for solution for injection vial This attribute specifies the numerator unit for the presentation strength of a product. True mg Inferred relationship Some 1
Product containing precisely cefixime anhydrous (as cefixime) 40 milligram/1 milliliter conventional release oral suspension (clinical drug) This attribute specifies the numerator unit for the concentration strength of a product. False mg Inferred relationship Some 1
Product containing precisely mucin 35 milligram/1 milliliter conventional release oral spray (clinical drug) This attribute specifies the numerator unit for the concentration strength of a product. False mg Inferred relationship Some 1
Lidocaine hydrochloride 40 mg/mL oropharyngeal solution This attribute specifies the numerator unit for the concentration strength of a product. True mg Inferred relationship Some 1
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) This attribute specifies the numerator unit for the presentation strength of a product. True mg Inferred relationship Some 2
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) This attribute specifies the numerator unit for the presentation strength of a product. True mg Inferred relationship Some 1
Somatrem 10 mg powder for solution for injection vial This attribute specifies the numerator unit for the presentation strength of a product. True mg Inferred relationship Some 1
Product containing precisely carmustine 7.7 milligram/1 each prolonged-release intralesional implant (clinical drug) This attribute specifies the numerator unit for the presentation strength of a product. True mg Inferred relationship Some 1
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet This attribute specifies the numerator unit for the presentation strength of a product. True mg Inferred relationship Some 2
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet This attribute specifies the numerator unit for the presentation strength of a product. True mg Inferred relationship Some 1
Lidocaine 25 mg/mL and prilocaine 25 mg/mL dental gel This attribute specifies the numerator unit for the concentration strength of a product. True mg Inferred relationship Some 1
Lidocaine 25 mg/mL and prilocaine 25 mg/mL dental gel This attribute specifies the numerator unit for the concentration strength of a product. True mg Inferred relationship Some 2
Product containing precisely amoxicillin anhydrous (as amoxicillin) 200 milligram and clavulanic acid (as clavulanate potassium) 28.5 milligram/1 each conventional release chewable tablet (clinical drug) This attribute specifies the numerator unit for the presentation strength of a product. False mg Inferred relationship Some 1
Product containing precisely amoxicillin anhydrous (as amoxicillin) 200 milligram and clavulanic acid (as clavulanate potassium) 28.5 milligram/1 each conventional release chewable tablet (clinical drug) This attribute specifies the numerator unit for the presentation strength of a product. False mg Inferred relationship Some 2
Product containing precisely doxycycline monohydrate 100 milligram/1 each conventional release orodispersible tablet (clinical drug) This attribute specifies the numerator unit for the presentation strength of a product. False mg Inferred relationship Some 1
Sodium cromoglicate 20 mg/actuation powder for inhalation This attribute specifies the numerator unit for the presentation strength of a product. True mg Inferred relationship Some 1
Dinoprostone 10 mg prolonged-release vaginal pessary This attribute specifies the numerator unit for the presentation strength of a product. True mg Inferred relationship Some 1
Product containing precisely amoxicillin anhydrous (as amoxicillin) 60 milligram/1 milliliter conventional release oral suspension (clinical drug) This attribute specifies the numerator unit for the concentration strength of a product. False mg Inferred relationship Some 1
Sulfasalazine 30 mg/mL rectal suspension This attribute specifies the numerator unit for the concentration strength of a product. True mg Inferred relationship Some 1
Product containing precisely amoxicillin anhydrous (as amoxicillin) 775 milligram/1 each prolonged-release oral tablet (clinical drug) This attribute specifies the numerator unit for the presentation strength of a product. False mg Inferred relationship Some 1
Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial This attribute specifies the numerator unit for the presentation strength of a product. True mg Inferred relationship Some 1
Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial This attribute specifies the numerator unit for the presentation strength of a product. True mg Inferred relationship Some 2
Product containing precisely amoxicillin anhydrous (as amoxicillin) 250 milligram and clavulanic acid (as clavulanate potassium) 62.5 milligram/1 each conventional release chewable tablet (clinical drug) This attribute specifies the numerator unit for the presentation strength of a product. False mg Inferred relationship Some 2
Product containing precisely amoxicillin anhydrous (as amoxicillin) 250 milligram and clavulanic acid (as clavulanate potassium) 62.5 milligram/1 each conventional release chewable tablet (clinical drug) This attribute specifies the numerator unit for the presentation strength of a product. False mg Inferred relationship Some 1
Hexachlorophene 30 mg/mL cutaneous emulsion This attribute specifies the numerator unit for the concentration strength of a product. True mg Inferred relationship Some 1
Product containing precisely mitomycin 40 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) This attribute specifies the numerator unit for the presentation strength of a product. False mg Inferred relationship Some 1
Product containing precisely lidocaine hydrochloride 40 milligram/1 milliliter conventional release cutaneous solution (clinical drug) This attribute specifies the numerator unit for the concentration strength of a product. True mg Inferred relationship Some 1
Product containing precisely mitomycin 5 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) This attribute specifies the numerator unit for the presentation strength of a product. False mg Inferred relationship Some 1
Selenium sulfide 25 mg/mL cutaneous lotion This attribute specifies the numerator unit for the concentration strength of a product. True mg Inferred relationship Some 1
Adrenaline 1 microgram/mg and lidocaine hydrochloride 100 microgram/mg cutaneous patch This attribute specifies the denominator unit for the concentration strength of a product. True mg Inferred relationship Some 1
Adrenaline 1 microgram/mg and lidocaine hydrochloride 100 microgram/mg cutaneous patch This attribute specifies the denominator unit for the concentration strength of a product. True mg Inferred relationship Some 2
Product containing precisely acetic acid 2.5 milligram/1 milliliter conventional release solution for irrigation (clinical drug) This attribute specifies the numerator unit for the concentration strength of a product. True mg Inferred relationship Some 1
Product containing precisely azithromycin anhydrous (as azithromycin monohydrate) 10 milligram/1 milliliter conventional release eye solution (clinical drug) This attribute specifies the numerator unit for the concentration strength of a product. False mg Inferred relationship Some 1
Product containing precisely azithromycin anhydrous (as azithromycin monohydrate) 20 milligram/1 milliliter conventional release oral suspension (clinical drug) This attribute specifies the numerator unit for the concentration strength of a product. False mg Inferred relationship Some 1
Product containing precisely amoxicillin anhydrous (as amoxicillin) 120 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 8.58 milligram/1 milliliter conventional release oral suspension (clinical drug) This attribute specifies the numerator unit for the concentration strength of a product. False mg Inferred relationship Some 1
Product containing precisely amoxicillin anhydrous (as amoxicillin) 120 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 8.58 milligram/1 milliliter conventional release oral suspension (clinical drug) This attribute specifies the numerator unit for the concentration strength of a product. False mg Inferred relationship Some 2
Product containing precisely cytarabine 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) This attribute specifies the numerator unit for the presentation strength of a product. True mg Inferred relationship Some 1
Lidocaine 50 microgram/mg cutaneous patch This attribute specifies the denominator unit for the concentration strength of a product. True mg Inferred relationship Some 1
Product containing precisely doxycycline anhydrous (as doxycycline calcium) 10 milligram/1 milliliter conventional release oral suspension (clinical drug) This attribute specifies the numerator unit for the concentration strength of a product. True mg Inferred relationship Some 1
Product containing precisely tesamorelin (as tesamorelin acetate) 1 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) This attribute specifies the numerator unit for the presentation strength of a product. False mg Inferred relationship Some 1
Product containing precisely amoxicillin anhydrous (as amoxicillin) 80 milligram/1 milliliter conventional release oral suspension (clinical drug) This attribute specifies the numerator unit for the concentration strength of a product. False mg Inferred relationship Some 1
Product containing precisely amoxicillin anhydrous (as amoxicillin) 250 milligram/1 each conventional release chewable tablet (clinical drug) This attribute specifies the numerator unit for the presentation strength of a product. False mg Inferred relationship Some 1
Product containing precisely dyclonine hydrochloride 5 milligram/1 milliliter conventional release cutaneous solution (clinical drug) This attribute specifies the numerator unit for the concentration strength of a product. True mg Inferred relationship Some 1
Ceftizoxime (as ceftizoxime sodium) 500 mg powder for solution for injection vial This attribute specifies the numerator unit for the presentation strength of a product. True mg Inferred relationship Some 1
Cefaclor anhydrous (as cefaclor) 75 mg/mL oral suspension This attribute specifies the numerator unit for the concentration strength of a product. True mg Inferred relationship Some 1
Product containing precisely somatrem 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) This attribute specifies the numerator unit for the presentation strength of a product. True mg Inferred relationship Some 1
Product containing precisely clavulanic acid (as clavulanate potassium) 1 milligram and ticarcillin (as ticarcillin disodium) 30 milligram/1 vial powder for conventional release solution for injection (clinical drug) This attribute specifies the numerator unit for the presentation strength of a product. False mg Inferred relationship Some 1
Product containing precisely clavulanic acid (as clavulanate potassium) 1 milligram and ticarcillin (as ticarcillin disodium) 30 milligram/1 vial powder for conventional release solution for injection (clinical drug) This attribute specifies the numerator unit for the presentation strength of a product. False mg Inferred relationship Some 2
Product containing precisely amoxicillin anhydrous (as amoxicillin) 25 milligram/1 milliliter conventional release oral suspension (clinical drug) This attribute specifies the numerator unit for the concentration strength of a product. False mg Inferred relationship Some 1
Product containing precisely mandelic acid 10 milligram/1 milliliter conventional release solution for irrigation (clinical drug) This attribute specifies the numerator unit for the concentration strength of a product. True mg Inferred relationship Some 1
Product containing precisely cefalexin anhydrous (as cefalexin) 25 milligram/1 milliliter conventional release oral solution (clinical drug) This attribute specifies the numerator unit for the concentration strength of a product. False mg Inferred relationship Some 1
Lidocaine hydrochloride 20 mg/mL oromucosal spray This attribute specifies the numerator unit for the concentration strength of a product. True mg Inferred relationship Some 1

Start Previous Page 72 of 101 Next End


This concept is not in any reference sets

Back to Start